Last $1.36 USD
Change Today +0.0152 / 1.13%
Volume 663.0
ESMC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

escalon medical corp (ESMC) Snapshot

Open
$1.28
Previous Close
$1.34
Day High
$1.36
Day Low
$1.28
52 Week High
01/22/14 - $2.59
52 Week Low
10/28/13 - $1.12
Market Cap
10.2M
Average Volume 10 Days
8.1K
EPS TTM
$-0.05
Shares Outstanding
7.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ESCALON MEDICAL CORP (ESMC)

Related News

No related news articles were found.

escalon medical corp (ESMC) Related Businessweek News

No Related Businessweek News Found

escalon medical corp (ESMC) Details

Escalon Medical Corp. develops, manufactures, markets, and distributes ophthalmic medical devices and pharmaceuticals in the United States and Europe. It provides A-Scans, which provide information about the internal structure of the eye; B-Scans that are diagnostic tools, which supplies information to physicians where the media in the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device to provide detailed information about the anterior segment of the eye; and pachymeters, which measure the thickness of cornea. The company also offers color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; and Ispan intraocular gases which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery, as well as a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it provides viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; light source and fiber optic products that are used by vitreoretinal surgeons during surgery; and AXIS image management system for managing images through the Web from various devices regardless of modality, manufacturer, or location. The company sells its products primarily to teaching institutions, hospitals, and eye surgery centers through internal sales employees and independent sales representatives. Escalon Medical Corp. was founded in 1987 and is based in Ardmore, Pennsylvania.

58 Employees
Last Reported Date: 09/26/14
Founded in 1987

escalon medical corp (ESMC) Top Compensated Officers

Chief Executive Officer, President, General C...
Total Annual Compensation: $215.0K
Executive Chairman
Total Annual Compensation: $256.6K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $212.6K
Chief Operating Officer
Total Annual Compensation: $175.0K
Compensation as of Fiscal Year 2013.

escalon medical corp (ESMC) Key Developments

Escalon Medical Corp. Reports Un-Audited Consolidated Earnings Results for the Year Ended June 30, 2014

Escalon Medical Corp. reported un-audited consolidated earnings results for the year ended June 30, 2014. For the year, the company reported a net loss of $381,883 or $0.05 per share and a net loss from continuing operations of $349,532, or $0.05 per share. This compares to net income of $2.6 million, or $0.35 per share, for fiscal 2013, which includes a net gain of $3.9 million related to the sale of Drew and related debt settlement. The net loss from continuing operations was $1.2 million, or $0.16 per share, for fiscal 2013. The company reported revenue, net of $12.4 million compared to $11.5 million and loss from operations of $0.4 million compared to $1.2 million for the last year.

Escalon Medical Corp. Announces Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014

Escalon Medical Corp. announced earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, the company reported net income was $86,084, or $0.01 per share, compared to a net loss of $285,864, or $0.04 loss per share, for the same quarter ended March 31, 2013. Net revenues for the third quarter ended March 31, 2014 were $3.15 million, compared to $2.72 million for the same quarter ended March 31, 2013. Net loss for the nine months ended March 31, 2014 was $9,223, or $0 per share, compared to a net income of $3.27 million, or $0.44 per share, for the same period ended March 31, 2013. Net revenues for the nine months ended March 31, 2014 were $9.36 million, compared to $8.63 million for the same period ended March 31, 2013.

Escalon Medical Corp. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014

Escalon Medical Corp. reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, the company's revenues, net was $3,151,651 against $2,724,740 a year ago. Income from operations was $112,308 against loss from operations of $294,865 a year ago. Net income from continuing operations was $112,354 or $0.01 per basic and diluted share against net loss from continuing operations of $283,761 or $0.04 per basic and diluted share a year ago. Net income was $86,084 or $0.01 per basic and diluted share against net loss of $285,864 or $0.04 per basic and diluted share a year ago. For the nine months, the company's revenues, net was $9,360,219 against $8,635,078 a year ago. Income from operations was $60,719 against loss from operations of $781,847 a year ago. Net income from continuing operations was $68,426 or $0.01 per basic and diluted share against net loss from continuing operations of $781,424 or $0.10 per basic and diluted share a year ago. Net income was $9,223 against net income of $3,274,082 or $0.44 per basic and diluted share a year ago, which includes a net gain of $4.1 million related to the sale of Drew and related debt settlement.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ESMC:US $1.36 USD +0.0152

ESMC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ESMC.
View Industry Companies
 

Industry Analysis

ESMC

Industry Average

Valuation ESMC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ESCALON MEDICAL CORP, please visit www.escalonmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.